(Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the ...
28, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor ( ...
People also ask
What does TScan Therapeutics do?
Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the Earnings Calendar to see dates for ...
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
18 hours ago · Find the latest TScan Therapeutics, Inc. (TCRX) stock quote, history, news and other vital information to help you with your stock trading ...
Missing: relations | Show results with:relations
TScan Therapeutics, Inc. (US:TCRX) has 79 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC) ...
Rating
(4,975)
TScan Therapeutics (TCRX) will release its next earnings report on May 6, 2024. In the last quarter TScan Therapeutics reported -$0.289 EPS in relation to ...
Get TScan Therapeutics Inc (TCRX.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.